Congressional News and Perspective
ACP continues to advocate for Congress to prioritize a payment fix and include it in future legislation.
Advocacy in Action
In a recent amicus brief, ACP joined other leading health care organizations in supporting the U.S. Attorney General in combatting vaccine misinformation.
ACP Policy News
New policy brief emphasizes the influence of elected officials in advancing health equity.
In Case You Missed It
The Advisory Committee on Immunization Practices (ACIP) has released its 2024 Recommended Adult Immunization Schedule, which is simultaneously published in Annals of Internal Medicine and in the Center for Disease Control and Prevention's (CDC) Morbidity and Mortality Weekly Report (MMWR). The schedule includes new vaccines for respiratory syncytial virus (RSV), mpox, COVID-19, and a combination meningococcal conjugate-serogroup B meningococcal vaccine.
A video series by Dr. Sandra Adamson Fryhofer, M.D., MACP provides an in-depth analysis of the updates and changes included in ACIP's 2024 Adult Immunization Schedule. The new video series, along with other tools and resources to improve adult vaccination rates, can be found on the ACP Adult Immunization Hub.
ACP is calling on internal medicine physicians to contact your members of Congress to ask them to include a fix for the 2024 Medicare physician payment cut in the next available legislative package.
Visit ACP's Legislative Action Center to learn more and to take action. A sample email message is provided for you that includes space for you to personalize the letter.
Advocacy News From ACP
Open Letter to Congress Regarding Site-Neutral Payment and Billing Transparency Reform
Letter calling on Congress to act now to advance site-neutral payment and billing transparency reforms to protect against unfair billing practices that lead to excessive health care prices.
Novartis Pharmaceuticals Corp., v. Xavier Becerra, U.S. Secretary of Health & Human Services, et al.
In this amicus brief, the interested parties argue that America's unsustainably high prescription drug prices have substantial and escalating negative impacts on public health and patient outcomes.
ACP Advocate is copyrighted ©2024 by the American College of Physicians.